Drug Class: Topical steroids with anti-infectives
Usual Adult Dose for Tinea Corporis
Cream: Apply a thin film topically to the affected skin area(s) twice a day for 1 week
Comments:
- Not to be used longer than 2 weeks.
- If no clinical improvement is seen after 1 week of therapy, the diagnosis should be reviewed.
Lotion: Apply a sufficient amount topically to the affected skin area(s) twice a day
Comments:
- To be applied twice a day in the morning and evening.
- Not to be used longer than 2 weeks.
- If no clinical improvement is seen after 1 week of therapy, the diagnosis should be reviewed.
Usual Adult Dose for Tinea Cruris
Cream: Apply a thin film topically to the affected skin area(s) twice a day for 1 week
Comments:
- Not to be used longer than 2 weeks.
- If no clinical improvement is seen after 1 week of therapy, the diagnosis should be reviewed.
Lotion: Apply a sufficient amount topically to the affected skin area(s) twice a day
Comments:
- To be applied twice a day in the morning and evening.
- Not to be used longer than 2 weeks.
- If no clinical improvement is seen after 1 week of therapy, the diagnosis should be reviewed.
Usual Adult Dose for Tinea Pedis
Cream: Apply a sufficient amount topically to the affected skin area(s) twice a day for 2 weeks
Comments:
- Not to be used longer than 4 weeks.
- If no clinical improvement is seen after 2 weeks of therapy, the diagnosis should be reviewed.
Lotion: Apply a sufficient amount topically to the affected skin area(s) twice a day
Comments:
- To be applied twice a day in the morning and evening.
- Not to be used longer than 4 weeks.
- If no clinical improvement is seen after 2 weeks of therapy, the diagnosis should be reviewed.
Usual Pediatric Dose for Tinea Corporis
17 years or older:
- Cream: Apply a thin film topically to the affected skin area(s) twice a day for 1 week
Comments:
- Not to be used longer than 2 weeks.
- If no clinical improvement is seen after 1 week of therapy, the diagnosis should be reviewed.
17 years or older:
- Lotion: Apply a sufficient amount topically to the affected skin area(s) twice a day
Comments:
- To be applied twice a day in the morning and evening.
- Not to be used longer than 2 weeks.
- If no clinical improvement is seen after 1 week of therapy, the diagnosis should be reviewed.
Usual Pediatric Dose for Tinea Cruris
17 years or older:
- Cream: Apply a thin film topically to the affected skin area(s) twice a day for 1 week
Comments:
- Not to be used longer than 2 weeks.
- If no clinical improvement is seen after 1 week of therapy, the diagnosis should be reviewed.
17 years or older:
- Lotion: Apply a sufficient amount topically to the affected skin area(s) twice a day
Comments:
- To be applied twice a day in the morning and evening.
- Not to be used longer than 2 weeks.
- If no clinical improvement is seen after 1 week of therapy, the diagnosis should be reviewed.
Usual Pediatric Dose for Tinea Pedis
17 years or older:
- Cream: Apply a sufficient amount topically to the affected skin area(s) twice a day for 2 weeks
Comments:
- Not to be used longer than 4 weeks.
- If no clinical improvement is seen after 2 weeks of therapy, the diagnosis should be reviewed.
17 years or older:
- Lotion: Apply a sufficient amount topically to the affected skin area(s) twice a day
Comments:
- To be applied twice a day in the morning and evening.
- Not to be used longer than 4 weeks.
- If no clinical improvement is seen after 2 weeks of therapy, the diagnosis should be reviewed.
Renal Dose Adjustments
Data not available
Liver Dose Adjustments
Data not available
Precautions
Safety and efficacy have not been established in patients younger than 17 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- For topical use only; not for oral, ophthalmic, or intravaginal use.
- Do not use more than 45 g of cream or 45 mL of lotion per week.
- Do not use occlusive dressings.
- Shake lotion well before each use.
- Use with caution on thinning skin.
Monitoring:
- Endocrine: Monitor for hypothalamic-pituitary-adrenal (HPA) axis suppression.
Patient advice:
- Contact your healthcare provider if signs of local adverse reactions occur.